Menorrhagia

Menorrhagia is a pathological condition characterized by heavy menstrual bleeding that may last more than seven days and is accompanied by a significant amount of blood loss. It is one of the most common menstrual disorders among women of reproductive age and can lead to anemia and other associated conditions. Menorrhagia can be caused by various reasons, including hormonal disorders, anatomical abnormalities, inflammatory processes, concomitant diseases and the use of medications such as anticoagulants. It is important that women suffering from menorrhagia receive timely diagnosis and treatment to prevent complications.

History of the disease and interesting historical facts

The word “menorrhagia” has Greek roots, where “menos” means “month” and “rageus” means “rupture” or “flow”. The first written references to menorrhagia are found in medical treatises of Ancient Egypt and Ancient Greece, where obstetricians and physicians tried to understand the nature of menstruation and the disorders associated with it. In the Middle Ages, various approaches to treating this condition emerged, including the use of herbal remedies and surgical interventions. Interestingly, many historical physicians associated heavy menstruation with mental disorders or divine curses. In the 19th century, with the development of gynecology and obstetrics, there was significant progress in the understanding of menorrhagia, as well as in its diagnosis and treatment.

Epidemiology

Menorrhagia occurs in 10-15% women of reproductive age, but it is in 25% of them that this condition becomes the reason for visiting a doctor. According to various studies, in the population of women aged 30 to 49 years, menorrhagia is observed in 25-30% cases. It can occur at any age, but is most often diagnosed in women aged 35-45 years. Epidemiological studies show that women with menorrhagia have a higher risk of developing anemia, especially iron deficiency, which emphasizes the importance of early detection and correction of this condition.

Genetic predisposition to this disease

Genetic predisposition plays an important role in the development of menorrhagia. Research has shown that certain genetic mutations can contribute to hormonal imbalances that lead to heavy menstrual bleeding. One such pathology is polycystic ovary syndrome, which can be inherited. Genetic variations that affect the metabolism of estrogens and other hormones may also be involved. For example, polymorphisms in the CYP450 genes, which are responsible for the metabolism of steroid hormones, may increase the risk of menorrhagia in women with certain clinical characteristics.

Risk factors for the development of this disease

The development of menorrhagia may be associated with a variety of risk factors, including:

• Hormonal disorders such as ovarian dysfunction or disorders in the hypothalamic-pituitary system.
• Anatomical abnormalities including uterine fibroids or polyps.
• The presence of concomitant diseases such as arthritis or thyroid disease.
• Taking anticoagulants such as warfarin.
• Hereditary predisposition to diseases associated with impaired hemostasis.
• Age (over 35 years), when the likelihood of menstrual cycle disorders increases.

Diagnosis of this disease

Diagnosis of menorrhagia involves a comprehensive approach that allows us to establish both the underlying cause of the bleeding and its severity. The main symptoms of this condition include:

• Heavy menstrual flow requiring the use of several hygiene products per day.
• Duration of menstruation is more than seven days.
• Presence of blood clots.
• Associated symptoms such as anemia, weakness and fatigue.

Laboratory tests may include a complete blood count to assess hemoglobin and hematocrit levels, as well as testing for infections or hormonal imbalances. Radiologic tests, such as pelvic ultrasound, may help identify anatomical abnormalities.

Other diagnostic tests may include hysteroscopy and endometrial biopsy to rule out malignancy. The differential diagnosis includes ruling out other causes of abnormal uterine bleeding, such as less intense conditions such as oligomenorrhea or amenorrhea.

Treatment

Treatment for menorrhagia depends on the cause, severity, and needs of the patient. Common approaches include:

• Pharmacological treatment, which may include nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce bleeding, as well as hormonal therapy such as combined oral contraceptives.
• Surgical intervention, if conservative treatment is ineffective, may include myomectomy or hysterectomy depending on the type and size of pathologies.
• Other treatment options include uterine artery embolization, which helps reduce bleeding from uterine fibroids.

List of medications used to treat this disease

Medications used to treat menorrhagia include:

• Combined oral contraceptives (eg, ethinyl estradiol + levonorgestrel).
• NSAIDs (eg, ibuprofen, naproxen).
• Progesterone-based hormone therapy (eg, medroxyprogesterone).
• Drugs that improve hemostasis (eg, desmopressin).
• Estrogens for hormonal balance correction.

Disease monitoring

Monitoring of the patient's condition includes monitoring of hemoglobin levels and symptoms, as well as regular examinations to assess the effectiveness of treatment. The prognosis with adequate treatment is generally favorable. It is important to consider the possibility of complications, such as severe anemia requiring blood transfusions or the development of recurrent menorrhagia.

Age-related features of the disease

Menorrhagia may present differently depending on age group. In adolescents, menorrhagia is often associated with poor hormonal regulation and may improve as the menstrual cycle becomes established. In women of reproductive age, the most common causes are fibroids and polyps. In menopausal or postmenopausal women, menorrhagia may indicate more serious pathologies, such as malignancies, and requires a comprehensive examination.

Questions and Answers

• What is menorrhagia? Menorrhagia is a condition that occurs when menstrual bleeding is heavy, exceeds the normal amount, and lasts more than 7 days.
• What are the symptoms of menorrhagia? The main symptoms include heavy menstrual bleeding, periods lasting more than 7 days, the presence of blood clots, and manifestations of anemia such as weakness and fatigue.
• What are the risk factors for developing menorrhagia? Risk factors include hormonal imbalances, anatomical abnormalities, the presence of concomitant diseases, age, and genetic predisposition.
• How is menorrhagia diagnosed? Diagnosis includes assessment of clinical manifestations, laboratory tests (complete blood count) and radiological examinations (ultrasound).
• What is the treatment for menorrhagia? Treatment may include pharmacological therapy (hormones, NSAIDs), surgical methods (myomectomy, hysterectomy) and other methods of correction (uterine artery embolization).